MARTINGALE ASSET MANAGEMENT L P - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 276 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 3.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARTINGALE ASSET MANAGEMENT L P ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$260,736
-1.8%
6,5070.0%0.01%0.0%
Q1 2023$265,551
-80.9%
6,507
-81.9%
0.01%
-81.5%
Q4 2022$1,390,617
-21.3%
36,017
+8.4%
0.03%
-22.9%
Q3 2022$1,768,000
+2.0%
33,213
+11.8%
0.04%
+9.4%
Q2 2022$1,733,000
-22.9%
29,712
+1.0%
0.03%
-5.9%
Q1 2022$2,247,000
+38.7%
29,421
+9.3%
0.03%
+61.9%
Q4 2021$1,620,000
+7.4%
26,9210.0%0.02%
+5.0%
Q3 2021$1,508,000
+254.8%
26,921
+284.4%
0.02%
+300.0%
Q2 2021$425,000
-13.4%
7,0030.0%0.01%
-16.7%
Q1 2021$491,000
-4.7%
7,003
-18.6%
0.01%0.0%
Q4 2020$515,000
-52.0%
8,603
-51.7%
0.01%
-53.8%
Q3 2020$1,072,000
-25.0%
17,817
-34.5%
0.01%
-23.5%
Q2 2020$1,429,000
+56.5%
27,2220.0%0.02%
+41.7%
Q1 2020$913,000
-19.3%
27,222
-8.4%
0.01%0.0%
Q1 2019$1,132,000
-13.0%
29,721
-1.6%
0.01%
-29.4%
Q4 2018$1,301,000
+534.6%
30,219
+1213.9%
0.02%
+240.0%
Q1 2015$205,000
-3.8%
2,300
-4.2%
0.01%
-16.7%
Q4 2014$213,000
-73.2%
2,402
-70.7%
0.01%
-76.0%
Q3 2014$796,0008,2040.02%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Key Colony Management, LLC 221,000$7,454,0009.50%
Sarissa Capital Management LP 653,000$22,025,0006.25%
Standard Investments LLC 775,388$26,154,0003.55%
Asymmetry Capital Management, L.P. 41,707$1,407,0002.58%
Tamarack Advisers, LP 190,000$6,409,0002.46%
DARUMA CAPITAL MANAGEMENT LLC 1,076,724$36,318,0002.37%
Biondo Investment Advisors, LLC 164,827$5,560,0001.98%
Stonepine Capital Management, LLC 52,157$1,759,0001.80%
GILDER GAGNON HOWE & CO LLC 2,033,432$68,588,0001.36%
Rock Springs Capital Management LP 472,500$15,937,0001.18%
View complete list of PACIRA PHARMACEUTICALS INC shareholders